Results 341 to 350 of about 5,263,232 (399)

Identification of FADS2 as a Contributor of Ferroptosis Escape in Bladder Cancer. [PDF]

J Cell Mol Med
Li P, Yao S, Qi W, Liu H, Zhang X, Zhou B, Zhang S, Zhang Y, Liang H, Huang H, Zhao Y, Shi B, Chen J, Liu J.   +13 more
europepmc   +1 more source

Cerium oxide-embedded gold nanoparticles loaded with astragaloside IV for bladder cancer therapy. [PDF]

Sci Rep
Zhu X, Yin X, Niu L, Yang G, Xu Y, Yu Y, Cheng Y, Ma X, Huang T, Wei W, Tao F.   +10 more
europepmc   +1 more source

Exploring Potential for Repurposing Antiretroviral Drugs Etravirine and Efavirenz in Prostate and Bladder Cancer. [PDF]

Pharmaceuticals (Basel)
Pereira M, Vale N.
europepmc   +1 more source

Non-muscle invasive bladder cancer in a pregnant patient. [PDF]

Urol Case Rep
van Jaarsveld N, John J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bladder cancer.

Current Opinion in Oncology, 1998
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
H. Ozen
semanticscholar   +9 more sources